Literature DB >> 21840549

Effect of hiatal hernia size and columnar segment length on the success of radiofrequency ablation for Barrett's esophagus: a single-center, phase II clinical trial.

Robert J Korst1, Sobeida Santana-Joseph, John R Rutledge, Arthur Antler, Vivian Bethala, Anthony DeLillo, Donald Kutner, Benjamin E Lee, Haleh Pazwash, Robert H Pittman, Michael Rahmin, Mitchell Rubinoff.   

Abstract

OBJECTIVE: Hiatal hernia is common in patients with Barrett's esophagus. We sought to evaluate the effect of hiatal hernia size and initial columnar segment length on the success of radiofrequency ablation of Barrett's esophagus.
METHODS: A phase II clinical trial was conducted aimed at evaluating the success of radiofrequency ablation in eradicating Barrett's esophagus. Success was defined as complete replacement of the columnar lining with squamous mucosa and lack of intestinal metaplasia using light microscopy. Hiatal hernia size and columnar segment length were measured endoscopically.
RESULTS: Sixty-seven patients were accrued to the protocol. In the 55 patients who completed radiofrequency ablation (43 successes, 12 failures), the mean hiatal hernia size was 3.3 cm (range, 0-10 cm), and the mean columnar segment length was 5.4 cm (range, 1-18 cm). The median length of the columnar segment was 3 cm in the successful cases and 8.5 cm in the failed cases (P = .002). Although the median hiatal hernia size was identical in the successful and failed cases (3 cm, P = .38), the median hiatal hernia size was 7 cm (P = .001) in the 6 patients who experienced nonhealing after the initial ablation. Patients who were successfully ablated but had larger hiatal hernias and longer columnar segment lengths required significantly more radiofrequency ablation sessions than those with smaller hernias and shorter segments (P = .003 and P = .007, respectively).
CONCLUSIONS: Patients with larger hiatal hernias and longer columnar segments are more likely to experience failure or nonhealing after radiofrequency ablation. These patients also require more radiofrequency ablation treatments to achieve successful eradication of Barrett's esophagus.
Copyright © 2011 The American Association for Thoracic Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21840549     DOI: 10.1016/j.jtcvs.2011.07.037

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  8 in total

Review 1.  Endoscopic treatments for dysplastic Barrett's esophagus: resection, ablation, what else?

Authors:  Charumathi Raghu Subramanian; George Triadafilopoulos
Journal:  World J Surg       Date:  2015-03       Impact factor: 3.352

2.  Positive correlation between endoscopist radiofrequency ablation volume and response rates in Barrett's esophagus.

Authors:  David I Fudman; Charles J Lightdale; John M Poneros; Gregory G Ginsberg; Gary W Falk; Maureen Demarshall; Milli Gupta; Prasad G Iyer; Lori Lutzke; Kenneth K Wang; Julian A Abrams
Journal:  Gastrointest Endosc       Date:  2014-02-22       Impact factor: 9.427

3.  Recurrence of cancer after endoscopic ablation of Barrett's esophagus: is the elephant in the room...persistent ongoing reflux?

Authors:  Seth A Gross; Prateek Sharma
Journal:  Dig Dis Sci       Date:  2014-07       Impact factor: 3.199

4.  Adherence to therapy for Barrett's esophagus-associated neoplasia.

Authors:  Lisa Cassani; James C Slaughter; Patrick Yachimski
Journal:  United European Gastroenterol J       Date:  2015-05-05       Impact factor: 4.623

5.  Significance of Nissen fundoplication after endoscopic radiofrequency ablation of Barrett's esophagus.

Authors:  Ognjan Skrobić; Aleksandar Simić; Nebojša Radovanović; Nenad Ivanović; Marjan Micev; Predrag Peško
Journal:  Surg Endosc       Date:  2015-12-10       Impact factor: 4.584

6.  Safety and efficacy of endoscopic mucosal therapy with radiofrequency ablation for patients with neoplastic Barrett's esophagus.

Authors:  William J Bulsiewicz; Hannah P Kim; Evan S Dellon; Cary C Cotton; Sarina Pasricha; Ryan D Madanick; Melissa B Spacek; Susan E Bream; Xiaoxin Chen; Roy C Orlando; Nicholas J Shaheen
Journal:  Clin Gastroenterol Hepatol       Date:  2012-10-25       Impact factor: 11.382

Review 7.  Precision care for Barrett's esophagus.

Authors:  George Triadafilopoulos; Shai Friedland
Journal:  Transl Gastroenterol Hepatol       Date:  2018-09-17

8.  Managing Barrett's esophagus with radiofrequency ablation.

Authors:  Junichi Akiyama; Andrew Roorda; George Triadafilopoulos
Journal:  Gastroenterol Rep (Oxf)       Date:  2013-03-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.